Cantabria Labs Portugal

What Cantabria Labs Portugal does

Cantabria Labs Portugal (legal entity: IFC Skincare Portugal – Produtos Dermatológicos, Unipessoal Lda., NIF 508906385) is the Portuguese operating subsidiary of the Spanish pharmaceutical group Industrial Farmacéutica Cantabria, S.A., headquartered in Lisbon. Founded in 2009 as part of Grupo Cantabria Labs, the entity develops, markets, and distributes dermatology, gynecology, and immune-health pharmaceutical and dermocosmetic products in Portugal. Its portfolio spans roughly a dozen primary and sub-brands — including Endocare (anti-aging with SCA® Growth Factor Technology), Heliocare (sun protection with ASPA-FERNBLOCK® and Fernblock®), Biretix (acne via BIOPEP 15), Neoretin (hyperpigmentation via RetinSphere®), Skin Resist, Rosacure, Aktuva, Iraltone and Cistitone (hair care), Folstim, KPL, CantabriaLabs Woman, and Inmunoferon — covering anti-aging, acne, hyperpigmentation, rosacea, reactive skin, actinic keratoses, hair loss, sun protection, women's health, and immune support. Underlying differentiation rests on six patented proprietary technologies (ASPA-FERNBLOCK®, SCA®, RetinSphere®, Fernblock®, BIOPEP 15, MetforHair®) backed by 20+ years of published clinical research.

Name

Cantabria Labs Portugal

Legal name

IFC Skincare Portugal – Produtos Dermatológicos, Unipessoal Lda.

Website

https://cantabrialabs.pt

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Cantabria Labs Portugal is a Lisbon-based pharmaceutical subsidiary of Spain's Industrial Farmacéutica Cantabria that markets dermatology, gynecology, and immune-health products across roughly a dozen proprietary brands to Portuguese consumers via pharmacies and physician detailing.

Ownership category

akta.pro rank

Product category

Dermatological Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Dermatology Specialty Pharmaceuticals (HLAIACAL)

Keywords

• Dermatological pharmaceuticals
• Photoprotection products
• Dermocosmetic formulations
• Pharmaceutical laboratory
• Hair care supplements

Headquarters

HQ city

Lisbon

HQ country

Portugal

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Dermatological pharmaceuticals and medical devices: Cantabria Labs Portugal generates revenue through the sale of dermatological pharmaceutical products, cosmetics, medical devices, and food supplements. Products are distributed through pharmacies and recommended by healthcare professionals including dermatologists and doctors.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Cantabria Labs Portugal develops, markets, and distributes a dermatology-focused portfolio of pharmaceuticals, medical devices, dermocosmetics, and food supplements covering anti-aging, photoprotection, acne, hyperpigmentation, rosacea, actinic keratoses, hair loss, desquamative conditions, women's health, and immune support. Products are INFARMED-authorized, distributed through Portuguese pharmacies, and recommended or prescribed by dermatologists, gynecologists, and other physicians reached via a field medical-sales force.

Product overview

Cantabria Labs Portugal is a pharmaceutical laboratory specializing in dermatology, offering a diversified portfolio of products across several therapeutic areas: dermatology (skincare, sun protection, anti-aging, acne, hyperpigmentation, rosacea, hair care, and actinic keratoses), women's health, medical devices, medications, and immune system supplements. The portfolio includes primary brands such as Endocare (anti-aging), Heliocare (sun protection with oral and topical formulations), Biretix (acne), Neoretin (hyperpigmentation), Skin Resist (reactive skin), Rosacure (rosacea), Iraltone and Cistitone (hair care supplements and topical treatments), and Aktuva (actinic keratoses), along with supporting lines for women's health (CantabriaLabs Woman), immune support (Inmunoferon), and prescription medications (Folcare/minoxidil).

Differentiator

Problem solved

Functional benefit

Brands

• Endocare: Anti-aging skincare brand featuring SCA Growth Factor Technology for skin repair and rejuvenation.
• Heliocare
• Iraltone
• Cistitone
• Biretix
• Neoretin
• Skin Resist
• Rosacure
• Aktuva
• KPL
• Folstim
• Inmunoferon

Products and services

• Endocare Anti-aging skincare brand featuring SCA Growth Factor Technology derived from Cryptomphalus aspersa secretion, targeting wrinkle reduction, skin firming, and regeneration. Includes the Endocare Hydractive hydrating sub-line and the Endocare Renewal retinoid-based advanced anti-aging sub-line.
• Heliocare Sun protection brand utilizing ASPA-FERNBLOCK technology combining Polypodium leucotomos and Aspalathus linearis extracts, offering topical 360º protection (UVB, UVA, visible, infrared) and oral photoprotection supplements. Includes Heliocare 360º (multi-format topical line), Heliocare 360º Pediatrics (from 6 months), Heliocare 360º Sport, and Heliocare Oral (capsules with vitamins and antioxidants).
• Biretix Acne treatment brand featuring BIOPEP 15 vegetable-origin technology, including cleansers, treatments, and the refillable Biretix Cleanser launched in 2024 to regulate excess oiliness and prevent proliferation of agents that alter skin condition.
• Iraltone Hair and scalp care line including shampoos (Reset Deep-Cleansing, Barrier Comfort Repair, Fortificante, Seboregulador), conditioner (Restore), leave-in treatment (Perfect10), hair repair oil (Sublime) with MetforHair technology, and oral supplements (Hair Efflu Booster, Hair Resilience Booster) for hair loss and scalp conditions.
• Cistitone Hair supplement line addressing seasonal hair loss, androgenetic alopecia, iron deficiency, and stress-related shedding, with capsule and tablet formats including Cistitone Forte, Cistitone Forte BD, Cistitone Agaxidil 5α Supreme, and Cistitone BD & Melatonina dual day/night system.
• Neoretin Hyperpigmentation treatment brand using RetinSphere technology combining hydroxypinacolone retinoate and stabilized encapsulated retinol for skin brightening and spot reduction, providing retinoic-acid-like efficacy with reduced adverse effects.
• Skin Resist Reactive and sensitive skin care line featuring anti-inflammaging formulations with Aquammunist and Skincalm Booster technologies including the Skin Resist Sensage Serum with Niacinamide for preventing and reversing signs of aging in reactive skin.
• Rosacure Rosacea treatment line classified as medical devices, including Rosacure Fast Emulsão-Gel for acute-phase erythema, stinging, and burning sensations, and Rosacure Gentle Cleansing Gel for daily hygiene of rosacea-prone skin in erythematous-telangiectatic and papulopustular phases.
• Aktuva Actinic keratoses treatment product for dermatological use within the Cantabria Labs prescription dermatology portfolio.
• KPL Product line addressing desquamative (scaly skin) conditions within the Cantabria Labs dermatology portfolio.
• CantabriaLabs Woman Women's health product line addressing menopause symptoms, vaginal flora alterations, urinary discomfort, and pregnancy supplementation, developed to respond to principal conditions affecting women's health.
• Inmunoferon Immune system support supplement product marketed under the Cantabria Labs food supplement category.
• Folcare Minoxidil 50 mg/ml Prescription topical medication containing 50mg/ml minoxidil for cutaneous application in the treatment of androgenetic alopecia and alopecia areata, authorized by INFARMED for use by healthcare professionals authorized to prescribe medicines in Portugal.

Quantifiable outcome

• 81% of users reported matte skin without existing imperfections after using Biretix Cleanser
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• Bioderma: NAOS-owned French dermo-cosmetic brand sold in Portuguese pharmacies with sensitive skin, acne, and sun protection ranges — direct competitor across Cantabria Labs' Biretix, Skin Resist, and Heliocare franchises.
• La Roche-Posay: L'Oréal-owned dermatology brand with a Portugal presence and broad pharmacy-distributed portfolio (Anthelios sun protection, Effaclar acne, Rosaliac rosacea) — directly comparable to Cantabria Labs' Heliocare, Biretix, and Rosacure franchises.
• Galderma: Global dermatology pharmaceutical pure-play (acne, rosacea, actinic keratosis) — comparable to Cantabria Labs' Aktuva (actinic keratoses), Biretix (acne), and Rosacure (rosacea) prescription and medical-device lines.
• Eucerin: Beiersdorf dermatology brand distributed in Portuguese pharmacies with ranges for acne, anti-aging, hyperpigmentation, and sun protection — directly comparable across most of Cantabria Labs' core sub-brands.
• ISDIN: Spanish-headquartered dermo-cosmetic and dermatology pharmaceutical company with strong sun protection (Fusion, SunBrush) and prescription franchises — closest Iberia-based peer to Cantabria Labs given shared Iberian HQ, pharmacy channel, and dermatology focus.
• Avène: Pierre Fabre dermo-cosmetic brand sold through Portuguese pharmacies with therapeutic skin, sun, and intolerance lines — overlapping directly with Cantabria Labs' Endocare, Skin Resist, and Heliocare categories.
• CeraVe: L'Oréal dermatology brand with strong acne, anti-aging, and sensitive skin portfolios sold via pharmacies and mass retail — direct comparable to Cantabria Labs' mass-pharmacy dermatology SKUs.
• SVR Laboratoires: French dermo-cosmetic laboratory distributed through pharmacies with topical ranges for acne, sun protection, anti-aging, and sensitive skin — comparable pharmacy-channel specialty dermatology positioning.

Broad incumbents

• Cantabria Labs (parent): Industrial Farmacéutica Cantabria, S.A. (Madrid) — the parent group operating in 80+ countries with the same Endocare, Heliocare, and other brand families. The Portugal entity is a regional affiliate of this broader incumbent.
• Pierre Fabre Dermatologie: Parent of Avène, Ducray, A-Derma, and prescription dermatology brands — broader incumbent with overlapping pharmacy-distributed dermo-cosmetic and prescription dermatology portfolio compared with Cantabria Labs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CantabriaLabsPT
• LinkedInlinkedin.com/company/cantabria-labs-portugal/mycompany
• Instagraminstagram.com/cantabrialabs_pt

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cantabria Labs Portugal